Fig. 3.
Cumulative incidence of nonrelapse mortality categorized by duration of therapy with IFN-α pretransplant. (A) 0 to 5 months of IFN-α pretransplant, 0.38 (n = 136). (B) ≥6 months of IFN-α pretransplant, 0.56 (n = 48) (P = .05, by the log-rank test).